Tiedemann Advisors, LLC Abb Vie Inc. Transaction History

Tiedemann Advisors, LLC

$2.31 Billion
Q3 2023

A detailed history of Tiedemann Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 25,535 shares of ABBV stock, worth $4.28 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

25,535

Previous 18,584 37.4%

Holding current value

$4.28 Million

Previous $2.5 Million 52.06%

% of portfolio

0.16%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $928,584 - $1.07 Million	6,951 Added 37.4%	25,535 $3.81 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $505,260 - $628,763	3,813 Added 25.81%	18,584 $2.5 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $575,692 - $662,995	3,981 Added 36.9%	14,771 $2.35 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $78,560 - $94,214	568 Added 5.56%	10,790 $1.74 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $56,905 - $65,266	-424 Reduced 3.98%	10,222 $1.37 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $365,243 - $464,343	-2,654 Reduced 19.95%	10,646 $1.63 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $185,959 - $230,723	-1,409 Reduced 9.58%	13,300 $2.16 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $32,336 - $40,914	-301 Reduced 2.01%	14,709 $1.99 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $644,677 - $731,806	-6,059 Reduced 28.76%	15,010 $1.62 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $53,762 - $59,894	-511 Reduced 2.37%	21,069 $2.38 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $40,510 - $44,597	-396 Reduced 1.8%	21,580 $2.34 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $99,405 - $134,207	-1,235 Reduced 5.32%	21,976 $2.35 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $27,319 - $32,063	318 Added 1.39%	23,211 $2.03 Million
Q2 2020 Nov 12, 2020	BUY	$73.37 - $98.18 $1.07 Million - $1.43 Million	14,616 Added 176.59%	22,893 $2.25 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $1.15 Million - $1.54 Million	-15,707 Reduced 65.49%	8,277 $811,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $90,622 - $137,394	-1,405 Reduced 5.53%	23,984 $1.83 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $665,543 - $832,736	9,227 Added 57.09%	25,389 $2.25 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $272,892 - $328,094	4,333 Added 36.63%	16,162 $1.23 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $109,653 - $140,162	-1,669 Reduced 12.36%	11,829 $861,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $69,348 - $81,620	-899 Reduced 6.24%	13,498 $1.09 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $152,352 - $187,891	1,957 Added 15.73%	14,397 $1.33 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $191,156 - $212,506	2,150 Added 20.89%	12,440 $1.18 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $288,283 - $341,104	3,211 Added 45.36%	10,290 $955,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $1,472 - $1,971	16 Added 0.23%	7,079 $669,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $282,472 - $309,754	-3,154 Reduced 30.87%	7,063 $683,000
Q3 2017 Nov 28, 2017	SELL	$69.85 - $89.22 $930,681 - $1.19 Million	-13,324 Reduced 56.6%	10,217 $766,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $115,950 - $148,105	1,660 Added 7.59%	23,541 $1.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,881	21,881 $1.59 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.

Account

Tiedemann Advisors, LLC Abb Vie Inc. Transaction History